Health
Study identifies therapeutic targets for most lethal pancreatic cancer – Drug Target Review
The detailed analysis of adenosquamous cancer of the pancreas (ASCP) suggested FGFR and RORC were two promising therapeutic targets.
Posted: 15 September 2020 | Hannah Balfour (Drug Target Review) | No comments yet
The detailed analysis of adenosquamous cancer of the pancreas (ASCP) suggested FGFR and RORC were two promising therapeutic targets.
Using preclinical models, researchers have identified two promising therapeutic targets for the most aggressive and lethal form of pancreatic cancer, adenosquamous cancer of the pancreas (ASCP).
The team of researchers led by Mayo Clinic and the Translational Genomics Research Inst…
-
General24 hours agoNewcastle Jets defeat semi-professional Heidelberg United 3-1 to lift first Australia Cup
-
Noosa News9 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
General13 hours agoEnglish springer spaniels Kelly and Milo helping fight dieback in Western Australia
-
General12 hours agoHomicide Squad investigating ‘suspicious’ death of 84yo woman in Sydney suburb of Melonba